Feb 29 |
Certara, Inc. (CERT) Lags Q4 Earnings Estimates
|
Feb 29 |
Certara Inc (CERT) Reports Modest Revenue Growth Amidst Net Loss in Q4 2023
|
Feb 29 |
Certara Non-GAAP EPS of $0.09 misses by $0.02, revenue of $88M beats by $1.32M
|
Feb 29 |
Certara Reports Fourth Quarter 2023 Financial Results
|
Feb 29 |
Earnings Scheduled For February 29, 2024
|
Feb 28 |
Certara Q4 2023 Earnings Preview
|
Feb 21 |
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?
|
Feb 1 |
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
|
Feb 1 |
Baillie Gifford Adjusts Position in Certara Inc
|
Jan 30 |
Certara: Applied BioMath Acquisition And Simcyp Launch Should Drive Growth
|